There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Ivacaftor is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator
recently approved for patients with CF age 6 and older with the G551D mutation.